Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report

Giuseppina Novo, Egle Corrado, Cinzia Nugara, Giuseppe Coppola, Antonino Mignano, Giusy Morgante, Giuseppina Novo, Antonino Saladino, Egle Corrado, Giuseppe Coppola

Risultato della ricerca: Articlepeer review

Abstract

Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan.
Lingua originaleEnglish
pagine (da-a)1349-1352
Numero di pagine4
RivistaClinical Case Reports
Volume8
Stato di pubblicazionePublished - 2020

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cita questo